-
The Michael J. Fox Foundation Announces Third Quarter Participants in Partnering Program Between Awardees and Industry
July 31, 2012
… studying eltoprazine as a treatment for levodopa-induced dyskinesias (LID) in PD. Completed pre-clinical work from …
-
Stephen J. Gold, PhD
… via which RGS9-2 inhibits the development of L-dopa-induced dyskinesias. In addition, his research aims to understand …
-
Targeting of the Raphe-Cortical Pathway to Reduce Levodopa-Induced Psychosis
… such as levodopa-induced movement disorders, or dyskinesia. Impact on Diagnosis/Treatment of Parkinson’s …
-
Michael J. Fox Foundation Research Staffers Reflect on 2012’s Highlights
December 24, 2012
… therapies to treat the symptoms of Parkinson’s disease, and dyskinesia , is strong. Novel drug candidates targeting … of research operations “I’m very happy with how many dyskinesia projects are moving into clinical testing, …
-
Latest in Parkinson’s Research Showcased at MJFF Conference
November 4, 2014
… decreased motor fluctuations — “off” time and dyskinesia — in people with moderate Parkinson’s disease. … time of over two hours and an improvement in time without dyskinesia. Drug levels remained at a consistent steady …
-
Dr. Dolhun Explains Deep Brain Stimulation and Focused Ultrasound as Treatments for Parkinson’s
December 20, 2024
… can ease tremor, slowness, stiffness and extra movement (dyskinesia) or muscle spasms (dystonia). They also may give … from levodopa but have side effects or complications like dyskinesia, “off” time (when symptoms return) or motor …